EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Artificial Tear Use as a Proxy for Dry Eye Disease: Prevalence and Associated Factors in the Hamburg City Health Study

Hegi Beliu, Carsten Grohmann, Vasyl Druchkiv, Birgit-Christiane Zyriax, Elena Butenko, Ansgar Beuse, Martin S. Spitzer, Christian Wolfram

Journal of Clinical & Translational Ophthalmology · 08.11.2026 · 4 (4) · 29

DOI: 10.3390/jcto4040029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical & Translational Ophthalmology, online erschienen am 08.11.2026. Verfasst von Hegi Beliu und 7 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Joachim Herz Foundation, Kühne Foundation, Leducq Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To the best of our knowledge, population-based studies about the prevalence of dry eye in Germany are rare. Our study aimed to reintroduce the topic of dry eye in the conversation about ophthalmological diseases and to analyze possible associated factors by assessing the usage of artificial tears as a proxy for treated dry eye in an older German population.

Methods

For this, data were gathered from the medication plan of the first cohort of participants of the Hamburg City Health Study (n = 10,000, aged 46–78 years old). Since artificial tears are a fundamental part of dry eye therapy, in this study consistent use of artificial tears was a proxy for treated dry eye. Lifestyle factors, pre-existing conditions and other medication were tested as possible associated factors.

Results

The calculated prevalence of self-reported artificial tear use in Hamburg was 4.7% (95% CI [4.2%; 5.1%]), with women being four times more likely to use them than men. Based on the definition, the prevalence of treated dry eye was 7.5% among women and 1.7% among men. A significant increase in the treated dry eye prevalence above the age of 58 was noticed as well.

Conclusions

This study provides empirical evidence of treated dry eye’s distribution and identifies possible factors associated with it.

Förderung

  • Joachim Herz Foundation
  • Kühne Foundation
  • Leducq Foundation
  • euCanSHare grant agreement
  • Max Delbrück Center-Berlin
  • Deutsche Gesetzliche Unfallversicherung
  • Deutsches Krebsforschungszentrum
  • Deutsches Zentrum für Herz-Kreislauf-Forschung

Zitieren

APA

Beliu, H., Grohmann, C., Druchkiv, V., Zyriax, B., Butenko, E., Beuse, A., Spitzer, M. S., & Wolfram, C. (2026). Artificial Tear Use as a Proxy for Dry Eye Disease: Prevalence and Associated Factors in the Hamburg City Health Study. Journal of Clinical & Translational Ophthalmology, 4(4), 29. https://doi.org/10.3390/jcto4040029

Vancouver

Beliu H, Grohmann C, Druchkiv V, Zyriax B, Butenko E, Beuse A, et al. Artificial Tear Use as a Proxy for Dry Eye Disease: Prevalence and Associated Factors in the Hamburg City Health Study. Journal of Clinical & Translational Ophthalmology. 2026;4(4):29. doi:10.3390/jcto4040029

BibTeX
@article{Beliu2026,
  author = {Beliu, Hegi and Grohmann, Carsten and Druchkiv, Vasyl and Zyriax, Birgit-Christiane and Butenko, Elena and Beuse, Ansgar and Spitzer, Martin S. and Wolfram, Christian},
  title = {Artificial Tear Use as a Proxy for Dry Eye Disease: Prevalence and Associated Factors in the Hamburg City Health Study},
  journal = {Journal of Clinical & Translational Ophthalmology},
  year = {2026},
  volume = {4},
  number = {4},
  pages = {29},
  doi = {10.3390/jcto4040029}
}
Kostenlos starten →